Publication

Article

Cardiology Review® Online

September 2008
Volume25
Issue 9

Patent foramen ovale closure in a young mother after a stroke

A 39-year-old mother of 2 teenage boys, who was also a nurse, became permanently aphasic because of a stroke.

A 39-year-old mother of 2 teenage boys, who was also a nurse, became permanently aphasic because of a stroke. Diligent workup found no cause, other than a patent foramen ovale (PFO) associated with an atrial septal aneurysm (Figure 1). The PFO was closed using a 25-mm Amplatzer® PFO Occluder (Figure 2) during an outpatient procedure. The patient was treated with clopidogrel (Plavix) for 1 month and aspirin for 5 months; no physical restrictions were prescribed. Endocarditis prophylaxis was recommended for the first 3 months. The 6-month follow-up transesophageal echocardiogram showed complete closure (Figure 3).

This particular case is anecdotal but nonetheless compelling. The patient had suffered from severe migraine headaches with aura for 10 years. If an evaluation for PFO had been performed earlier because of her migraines and the PFO closed before the stroke, the patient would have avoided the fate of coping with a lifelong disability, which was especially challenging because of her responsibility to raise 2 sons.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM  | Image Credit: Radcliffe Cardiology
© 2024 MJH Life Sciences

All rights reserved.